mk 0663 has been researched along with Ache in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (41.03) | 29.6817 |
| 2010's | 20 (51.28) | 24.3611 |
| 2020's | 3 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, JP; Dourado, M; Lira, L; Marques, D; Napoleão, L; Ribeiro, H; Rodrigues, I; Veríssimo, M | 1 |
| Chantawong, N; Mairaing, K; Pattaraarchachai, J; Poomtavorn, Y; Punyashthira, A; Sivapornpan, S; Suwannarurk, K; Thaweekul, Y; Wisarnsirirak, P | 1 |
| Hellstein, JW; Marek, CL | 1 |
| Wenckus, CS | 1 |
| Glick, M | 1 |
| Blanck-Lubarsch, M; Cieplik, F; Kirschneck, C; Proff, P; Schröder, A; Wolf, F | 1 |
| Chen, WJ; Gates, DF; Lin, HY; Moore, RA; Peloso, PM; Popmihajlov, Z; Straus, WL | 1 |
| Huang, WN; Tso, TK | 1 |
| Kokalj, A; Maquirriain, J | 1 |
| Aujla, U; Bjarnason, I; Kvasnovsky, CL | 1 |
| Dasgupta, A; Wang, R; Ward, MM | 1 |
| Arendt-Nielsen, L; Egsgaard, LL; Petersen, KK | 1 |
| Balazcs, E; Bickham, K; Frontera, N; Mehta, A; Peloso, PM; Popmihajlov, Z; Sieper, J; Stryszak, P | 1 |
| Khehra, HS; Piepho, HP; Sandhu, SS | 1 |
| Davies, NM; Remsberg, CM; Reynolds, JK; Takemoto, JK; Vega-Villa, KR | 1 |
| Derry, S; Gammaitoni, AR; Moore, OA; Moore, RA; Peloso, PM; Wang, H | 1 |
| Chen, MH; Chen, WJ; Cheng, TT; Gammaitoni, AR; Lac, C; Lee, CS; Lei, V; Lin, HY; Smugar, SS; Wang, JH | 1 |
| Bandy, DP; Boice, J; Christensen, SE; Daniels, SE; Liu, H; Losada, MC; Mehta, A; Peloso, PM | 1 |
| Aguiar, JA; Benevides, NM; Bezerra, MM; Brito, GA; Chaves, HV; da Graça, JR; Grangeiro, NM; Lima, V; Silva, AA | 1 |
| Janovsky, M; Krsiak, M | 1 |
| Boice, JA; Curtis, SP; Frontera, N; Greenwald, M; Mandel, D; Mehta, A; Peloso, PM; Soto, O; Zhan, XJ | 1 |
| Best, AE; Duan, WR; Faltynek, CR; Locke, C; Nothaft, W; Othman, AA; Reeh, P; Schaffler, K | 1 |
| Lories, RJ | 1 |
| Bockow, B; Curtis, S; DeTora, L; Fisher, C; Geissler, L; Gertz, BJ; Gottesdiener, K; Ko, A; Markenson, J; Schnitzer, T | 1 |
| Capell, HA; Duncan, MR | 1 |
| Antigua, J; Burton, R; Chen, E; Geba, GP; Londoño, J; Lund, M; Najarian, DK; Navarra, S; Ozturk, ZE; Petruschke, RA; Pryhuber, KG; Rubin, BR | 1 |
| Cavanaugh, PF; Matsumoto, AK | 1 |
| Baraf, HS; Calin, A; Dougados, M; James, M; Markind, JE; Melian, A; Ramos-Remus, C; Reicin, AS; Schiff, M; van der Heijde, D; Weaver, AL | 1 |
| Martina, SD; Ripley, TL; Vesta, KS | 1 |
| Ang, J; Fricke, JR; Malmstrom, K; Reicin, A; Shingo, S | 1 |
| Chiu, JW; Lim, Y; Liu, W; Loo, CC; Ren, HZ; Tan, HM | 1 |
| Hilário, MO; Len, CA; Terreri, MT | 1 |
| Carvalho, JC; do Amaral, BC; Moraes, BM; Morimoto, MS; Perazzo, FF; Vieira, LG | 1 |
| Klotz, U; Shi, S | 1 |
| Derry, S; McQuay, HJ; Moore, OA; Moore, RA | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Boice, JA; Daikh, DI; Malmstrom, K; Molina, J; Mukhopadhyay, S; Ng, J; Schumacher, HR; Tate, GA | 1 |
12 review(s) available for mk 0663 and Ache
| Article | Year |
|---|---|
Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features.
Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Pain; Prescriptions | 2022 |
Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Observational Studies as Topic; Pain; Pyrazoles; Pyridines; Recurrence; Sulfonamides; Sulfones | 2015 |
Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Etoricoxib; Humans; Network Meta-Analysis; Pain; Pyridines; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Sulfones | 2016 |
Comparing the effectiveness profile of pharmacological interventions used for orthodontic pain relief: an arm-based multilevel network meta-analysis of longitudinal data.
Topics: Acetaminophen; Analgesics; Drug Administration Schedule; Etoricoxib; Humans; Ibuprofen; Network Meta-Analysis; Orthodontics, Corrective; Pain; Pain Management; Randomized Controlled Trials as Topic | 2017 |
Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib.
Topics: Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Humans; Liver Failure; Osteoarthritis; Pain; Pyridines; Renal Insufficiency; Sulfones | 2008 |
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
Topics: Cyclooxygenase 2 Inhibitors; Diffusion of Innovation; Dose-Response Relationship, Drug; Etoricoxib; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome | 2010 |
Etoricoxib and the treatment of ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Etoricoxib; Gastrointestinal Diseases; Half-Life; Humans; Pain; Pyridines; Spondylitis, Ankylosing; Sulfones | 2012 |
Etoricoxib.
Topics: Arthritis; Clinical Trials as Topic; Cyclooxygenase 2; Etoricoxib; Hemarthrosis; Hemophilia A; Humans; Isoenzymes; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyridines; Spondylitis, Ankylosing; Sulfones | 2004 |
Etoricoxib: a highly selective COX-2 inhibitor.
Topics: Adult; Arthritis; Biological Availability; Cyclooxygenase Inhibitors; Dysmenorrhea; Etoricoxib; Female; Half-Life; Humans; Low Back Pain; Male; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfones | 2005 |
Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors.
Topics: Adolescent; Aspirin; Celecoxib; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Fever; Humans; Hypersensitivity, Immediate; Inflammation; Leukotrienes; Meloxicam; Naproxen; Pain; Prostaglandins; Pyrazoles; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Treatment Outcome | 2006 |
Clinical use and pharmacological properties of selective COX-2 inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Monitoring; Etoricoxib; Humans; Osteoarthritis; Pain; Pyrazoles; Pyridines; Sulfonamides; Sulfones | 2008 |
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.
Topics: Arthritis, Rheumatoid; Drug Administration Schedule; Etoricoxib; Humans; Musculoskeletal Diseases; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2008 |
16 trial(s) available for mk 0663 and Ache
| Article | Year |
|---|---|
The Efficacy of Oral Etoricoxib in Pain Control During Colposcopy-Directed Cervical Biopsy: A Randomized Control Trial.
Topics: Adult; Biopsy; Colposcopy; Etoricoxib; Female; Humans; Male; Pain; Pain Management; Pregnancy; Prospective Studies | 2023 |
Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
Topics: Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Ontario; Osteoarthritis; Pain; Pain Management; Pain Measurement; Pyridines; Quality of Life; Sulfones | 2016 |
Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Humans; Joints; Male; Osteoarthritis; Pain; Pain Measurement; Prospective Studies; Pyridines; Quality of Life; Sulfones; Treatment Outcome | 2018 |
Acute Achilles tendinopathy: effect of pain control on leg stiffness.
Topics: Achilles Tendon; Adult; Anti-Inflammatory Agents, Non-Steroidal; Athletes; Athletic Injuries; Etoricoxib; Humans; Leg; Male; Pain; Pain Measurement; Pyridines; Recovery of Function; Sulfones; Tendinopathy | 2014 |
Evidence for a central mode of action for etoricoxib (COX-2 inhibitor) in patients with painful knee osteoarthritis.
Topics: Aged; Central Nervous System Sensitization; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pain Threshold; Pyridines; Sulfones; Treatment Outcome | 2016 |
A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Pain; Pain Measurement; Pyridines; Spondylitis, Ankylosing; Sulfones; Treatment Outcome; Young Adult | 2016 |
Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial.
Topics: Aged; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Health Status; Humans; Male; Osteoarthritis; Pain; Patient Satisfaction; Prospective Studies; Pyridines; Quality of Life; Range of Motion, Articular; Recovery of Function; Severity of Illness Index; Sulfones; Surveys and Questionnaires; Treatment Failure; Treatment Outcome | 2010 |
Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.
Topics: Acetaminophen; Adolescent; Adult; Anesthesia, Dental; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Etoricoxib; Female; Humans; Ibuprofen; Least-Squares Analysis; Male; Molar, Third; Pain; Pain Measurement; Pain, Postoperative; Pyridines; Sulfones; Tooth Extraction; Tooth, Impacted; Treatment Outcome; Young Adult | 2011 |
Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
Topics: Aged; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Pain; Pyridines; Rheumatic Fever; Sulfones | 2011 |
An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Evoked Potentials; Hot Temperature; Humans; Indazoles; Lasers, Gas; Male; Pain; Pain Measurement; Pyridines; Severity of Illness Index; Skin; Sulfones; Tramadol; TRPV Cation Channels; Ultraviolet Rays; Urea | 2013 |
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Health Status; Humans; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pliability; Pyridines; Severity of Illness Index; Sulfones; Treatment Outcome | 2002 |
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
Topics: Administration, Oral; Double-Blind Method; Drug Administration Schedule; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pain; Pain Measurement; Pyridines; Sulfones; Treatment Outcome | 2004 |
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Pain; Pyridines; Severity of Illness Index; Spondylitis, Ankylosing; Sulfones; Treatment Outcome | 2005 |
The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
Topics: Acetaminophen; Acute Disease; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Codeine; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Etoricoxib; Female; Humans; Male; Oxycodone; Pain; Pain Measurement; Proportional Hazards Models; Pyridines; Sulfones; Tooth, Impacted; Treatment Outcome | 2005 |
Analgesic efficacy of pre-operative etoricoxib for termination of pregnancy in an ambulatory centre.
Topics: Abortion, Induced; Administration, Oral; Adult; Analgesics, Opioid; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Fentanyl; Humans; Length of Stay; Pain; Pain Measurement; Patient Satisfaction; Placebos; Pregnancy; Preoperative Care; Pyridines; Sulfones | 2005 |
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
Topics: Acute Disease; Adult; Aged; Arthritis, Gouty; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pain; Pain Measurement; Pyridines; Sulfones; Treatment Outcome | 2002 |
11 other study(ies) available for mk 0663 and Ache
| Article | Year |
|---|---|
MORE ON ETORICOXIB.
Topics: Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Pain | 2019 |
UNCOMMON ETORICOXIB.
Topics: Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Pain | 2019 |
Editor's response.
Topics: Etoricoxib; Humans; Pain | 2019 |
Impact of NSAID etoricoxib on side effects of orthodontic tooth movement.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Remodeling; Etoricoxib; Male; Models, Animal; Osteogenesis; Pain; Rats, Inbred F344; Staining and Labeling; Tartrate-Resistant Acid Phosphatase; Tooth Movement Techniques; Tooth Resorption | 2020 |
[Non-selective NSAIDs and coxibs: what are myths, what are facts?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Humans; Long-Term Care; Osteoarthritis; Pain; Pain Management; Pyridines; Sulfones; Treatment Outcome | 2013 |
Heme oxygenase/carbon monoxide-biliverdin pathway may be involved in the antinociceptive activity of etoricoxib, a selective COX-2 inhibitor.
Topics: Acetic Acid; Analgesics; Animals; Biliverdine; Carbon Monoxide; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Etoricoxib; Heme Oxygenase-1; Male; Mice; Pain; Pain Measurement; Pyridines; Sulfones | 2011 |
Codeine did not increase analgesic efficacy of coxibs in contrast to that of paracetamol or ibuprofen: isobolographic analysis in mice.
Topics: Acetaminophen; Acetic Acid; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Celecoxib; Codeine; Cyclooxygenase 2 Inhibitors; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Etoricoxib; Ibuprofen; Male; Mice; Mice, Inbred Strains; Models, Animal; Pain; Pyrazoles; Pyridines; Regression Analysis; Sulfonamides; Sulfones | 2011 |
Etoricoxib in the treatment of chronic pain.
Topics: Adult; Aged; Arthritis; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Gastrointestinal Diseases; Humans; Low Back Pain; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2003 |
Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Carrageenan; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Edema; Etoricoxib; Male; Mice; Misoprostol; Pain; Pain Measurement; Pyridines; Rats; Rats, Wistar; Sulfones | 2007 |
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.
Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Pilot Projects; Pyridines; Randomized Controlled Trials as Topic; Research Design; Sulfones | 2008 |
Investigational COX-2 inhibitor relieves pain in dental model.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Etoricoxib; Humans; Ibuprofen; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Tooth Extraction; Treatment Outcome | 2001 |